NPHCDA Immunization FHIR IG
0.7.0 - ci-build Nigeria flag

NPHCDA Immunization FHIR IG, published by https://nphcda.gov.ng. This guide is not an authorized publication; it is the continuous build for version 0.7.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/Nigeria-FHIR-Community/NPHCDA-ImmunizationIG/ and changes regularly. See the Directory of published versions

: Example NG-Imm Allergy Intolerance -001 - JSON Representation

Raw json | Download

{
  "resourceType" : "AllergyIntolerance",
  "id" : "allergyIntolerance-001",
  "meta" : {
    "profile" : [
      🔗 "http://nphcda.gov.ng/ig/immunization/StructureDefinition/allergy-intolerance-profile"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: AllergyIntolerance allergyIntolerance-001</b></p><a name=\"allergyIntolerance-001\"> </a><a name=\"hcallergyIntolerance-001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-allergy-intolerance-profile.html\">NG-Imm AllergyIntolerance</a></p></div><p><b>NG-Imm Allergy Dose Number</b>: 165</p><p><b>NG-Imm Dose Series</b>: Pentavalent Infant Series</p><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}\">Active</span></p><p><b>verificationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification confirmed}\">Confirmed</span></p><p><b>type</b>: Allergy</p><p><b>category</b>: Medication, Biologic</p><p><b>criticality</b>: High Risk</p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 293104008}\">Adverse reaction to immunization</span></p><p><b>patient</b>: <a href=\"Patient-patient-001.html\">Chinedu Emeka Okafor  Male, DoB: 2020-05-15 ( NIN)</a></p><p><b>encounter</b>: <a href=\"Encounter-encounter-001.html\">Encounter: extension = ; status = in-progress; class = PHC Center Level 2 (IMMZ.D.DE3 Facility Type CS#phc-center-l2)</a></p><p><b>onset</b>: 2025-08-01 09:30:00+0100</p><p><b>recordedDate</b>: 2025-08-01 10:00:00+0100</p><p><b>recorder</b>: <a href=\"Practitioner-practitioner-001.html\">Practitioner Nkiru Okafor </a></p><p><b>lastOccurrence</b>: 2025-08-01 12:00:00+0100</p><h3>Reactions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Substance</b></td><td><b>Manifestation</b></td><td><b>Description</b></td><td><b>Onset</b></td><td><b>Severity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 333346007}\">Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug)</span></td><td><span title=\"Codes:{http://snomed.info/sct 271807003}\">Skin rash</span></td><td>Patient developed rash and swelling within 30 minutes of immunization.</td><td>2025-08-01 10:15:00+0100</td><td>Moderate</td></tr></table></div>"
  },
  "extension" : [
    {
      "url" : "http://nphcda.gov.ng/ig/immunization/StructureDefinition/allergy-reference-dose-number",
      "valueInteger" : 165
    },
    {
      "url" : "http://nphcda.gov.ng/ig/immunization/StructureDefinition/allergy-reference-dose-series",
      "valueString" : "Pentavalent Infant Series"
    }
  ],
  "clinicalStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
        "code" : "active",
        "display" : "Active"
      }
    ]
  },
  "verificationStatus" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
        "code" : "confirmed",
        "display" : "Confirmed"
      }
    ]
  },
  "type" : "allergy",
  "category" : [
    "medication",
    "biologic"
  ],
  "criticality" : "high",
  "code" : {
    "coding" : [
      {
        "system" : "http://snomed.info/sct",
        "code" : "293104008",
        "display" : "Adverse reaction to immunization"
      }
    ]
  },
  "patient" : {
    🔗 "reference" : "Patient/patient-001"
  },
  "encounter" : {
    🔗 "reference" : "Encounter/encounter-001"
  },
  "onsetDateTime" : "2025-08-01T09:30:00+01:00",
  "recordedDate" : "2025-08-01T10:00:00+01:00",
  "recorder" : {
    🔗 "reference" : "Practitioner/practitioner-001"
  },
  "lastOccurrence" : "2025-08-01T12:00:00+01:00",
  "reaction" : [
    {
      "substance" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "333346007",
            "display" : "Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug)"
          }
        ]
      },
      "manifestation" : [
        {
          "coding" : [
            {
              "system" : "http://snomed.info/sct",
              "code" : "271807003",
              "display" : "Skin rash"
            }
          ]
        }
      ],
      "description" : "Patient developed rash and swelling within 30 minutes of immunization.",
      "onset" : "2025-08-01T10:15:00+01:00",
      "severity" : "moderate"
    }
  ]
}